The BCS Working Party for Ischaemic Heart Disease (IHD) would hugely appreciate responses to a survey of Prescriber Preferences for Clopidogrel or Aspirin Monotherapy. This brief survey explores the preferences for clopidogrel or aspirin monotherapy for long-term secondary prevention of cardiovascular events and the feasibility of a clinical trial.
If you would be happy to take part, please see further info and link to the survey: A Survey of Prescriber Preferences for Clopidogrel or Aspirin Monotherapy
It should only take a couple of minutes to complete and your input would be appreciated.